Noteworthy is that overexpression of KLK10 was found in malignant sample subsets (tissues or sera) in cancer types in which KLK10 was shown experimentally as tumor suppressor; breast [35], prostate [19], gastric [36] and ovary [20, 27]. Here, KLK10 is linked to cancer.